Nu Skin Enterprises (NYSE:NUS - Get Free Report) had its price target cut by research analysts at DA Davidson from $11.00 to $7.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. DA Davidson's price target points to a potential upside of 6.06% from the company's current price.
Other research analysts also recently issued reports about the stock. StockNews.com raised shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a report on Monday, November 11th. Citigroup dropped their target price on Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating on the stock in a research report on Tuesday, October 22nd.
Get Our Latest Stock Analysis on Nu Skin Enterprises
Nu Skin Enterprises Stock Performance
NUS traded down $0.27 during trading hours on Friday, hitting $6.60. The stock had a trading volume of 2,838,430 shares, compared to its average volume of 844,734. Nu Skin Enterprises has a 1 year low of $5.95 and a 1 year high of $20.75. The company's fifty day simple moving average is $6.98 and its 200 day simple moving average is $8.74. The stock has a market cap of $328.09 million, a PE ratio of -3.19 and a beta of 1.20. The company has a quick ratio of 1.20, a current ratio of 1.93 and a debt-to-equity ratio of 0.53.
Hedge Funds Weigh In On Nu Skin Enterprises
Hedge funds have recently bought and sold shares of the company. Virtu Financial LLC bought a new position in Nu Skin Enterprises in the 3rd quarter valued at $93,000. Barclays PLC raised its position in shares of Nu Skin Enterprises by 363.8% in the third quarter. Barclays PLC now owns 85,437 shares of the company's stock worth $629,000 after buying an additional 67,016 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Nu Skin Enterprises by 1.1% in the third quarter. Geode Capital Management LLC now owns 1,130,487 shares of the company's stock worth $8,333,000 after buying an additional 11,838 shares in the last quarter. Y Intercept Hong Kong Ltd boosted its stake in Nu Skin Enterprises by 760.7% during the third quarter. Y Intercept Hong Kong Ltd now owns 111,979 shares of the company's stock valued at $825,000 after buying an additional 98,969 shares during the period. Finally, XTX Topco Ltd purchased a new position in Nu Skin Enterprises during the third quarter worth about $416,000. Hedge funds and other institutional investors own 82.84% of the company's stock.
About Nu Skin Enterprises
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Stories
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
